Skip to main content
. 2021 Mar 29;11:7064. doi: 10.1038/s41598-021-85962-4

Figure 1.

Figure 1

Tumor volume evolution (panels A and B) and residual cellularity (panels C and D) in PDX from patients with and without mutations in genes involved in homologous recombination. ns, nonsignificant; *p < 0.05; **p < 0.005; ***p < 0.0005; Dc, docetaxel; Cb, carboplatin; V, vehicle; Dx, doxorubicin; Dc + Cb: docetaxel plus carboplatin.